nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—PTGS1—Valproic Acid—migraine	0.0181	1	CbGbCtD
Mesalazine—PPARG—Differentiation of white and brown adipocyte   —PRDM16—migraine	0.0169	0.112	CbGpPWpGaD
Mesalazine—IKBKB—Type II diabetes mellitus—CACNA1A—migraine	0.0066	0.044	CbGpPWpGaD
Mesalazine—MPO—blood vessel—migraine	0.00573	0.0648	CbGeAlD
Mesalazine—CHUK—cardiovascular system—migraine	0.00536	0.0606	CbGeAlD
Mesalazine—PPARG—blood vessel—migraine	0.00508	0.0575	CbGeAlD
Mesalazine—IKBKB—cardiovascular system—migraine	0.00364	0.0412	CbGeAlD
Mesalazine—PPARG—neck—migraine	0.00364	0.0411	CbGeAlD
Mesalazine—CHUK—head—migraine	0.00363	0.041	CbGeAlD
Mesalazine—CHUK—cerebellum—migraine	0.00324	0.0366	CbGeAlD
Mesalazine—ALOX5—cardiovascular system—migraine	0.00302	0.0341	CbGeAlD
Mesalazine—PPARG—Nuclear Receptors—PGR—migraine	0.00276	0.0184	CbGpPWpGaD
Mesalazine—PTGS1—blood vessel—migraine	0.00272	0.0307	CbGeAlD
Mesalazine—CHUK—Apoptosis—LTA—migraine	0.00268	0.0179	CbGpPWpGaD
Mesalazine—CHUK—brain—migraine	0.00263	0.0297	CbGeAlD
Mesalazine—PTGS2—blood vessel—migraine	0.0026	0.0294	CbGeAlD
Mesalazine—MPO—cardiovascular system—migraine	0.00256	0.0289	CbGeAlD
Mesalazine—IKBKB—head—migraine	0.00247	0.0279	CbGeAlD
Mesalazine—IKBKB—Apoptosis—LTA—migraine	0.00243	0.0162	CbGpPWpGaD
Mesalazine—Dopamine—HTR7—migraine	0.00242	0.413	CrCbGaD
Mesalazine—CHUK—B Cell Receptor Signaling Pathway—MEF2D—migraine	0.00239	0.0159	CbGpPWpGaD
Mesalazine—IKBKB—nervous system—migraine	0.00234	0.0264	CbGeAlD
Mesalazine—PPARG—cardiovascular system—migraine	0.00227	0.0256	CbGeAlD
Mesalazine—IKBKB—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.00226	0.015	CbGpPWpGaD
Mesalazine—IKBKB—central nervous system—migraine	0.00225	0.0255	CbGeAlD
Mesalazine—MPO—Vitamin B12 Metabolism—MTHFR—migraine	0.00224	0.0149	CbGpPWpGaD
Mesalazine—PTGS1—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.00223	0.0148	CbGpPWpGaD
Mesalazine—IKBKB—cerebellum—migraine	0.0022	0.0249	CbGeAlD
Mesalazine—PPARG—Nuclear Receptor transcription pathway—PGR—migraine	0.00218	0.0145	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Receptor Signaling Pathway—MEF2D—migraine	0.00217	0.0144	CbGpPWpGaD
Mesalazine—CHUK—Estrogen signaling pathway—ESR1—migraine	0.00207	0.0138	CbGpPWpGaD
Mesalazine—ALOX5—head—migraine	0.00205	0.0231	CbGeAlD
Mesalazine—PPARG—Adipogenesis—MEF2D—migraine	0.00201	0.0134	CbGpPWpGaD
Mesalazine—ALOX5—nervous system—migraine	0.00194	0.0219	CbGeAlD
Mesalazine—IKBKB—Estrogen signaling pathway—ESR1—migraine	0.00187	0.0125	CbGpPWpGaD
Mesalazine—ALOX5—central nervous system—migraine	0.00187	0.0211	CbGeAlD
Mesalazine—CHUK—Estrogen signaling pathway—FOS—migraine	0.00186	0.0124	CbGpPWpGaD
Mesalazine—Dopamine—HTR1A—migraine	0.00185	0.317	CrCbGaD
Mesalazine—ALOX5—cerebellum—migraine	0.00182	0.0206	CbGeAlD
Mesalazine—MPO—Folate Metabolism—MTHFR—migraine	0.00182	0.0121	CbGpPWpGaD
Mesalazine—IKBKB—brain—migraine	0.00179	0.0202	CbGeAlD
Mesalazine—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.00177	0.0118	CbGpPWpGaD
Mesalazine—MPO—head—migraine	0.00173	0.0196	CbGeAlD
Mesalazine—CHUK—Validated nuclear estrogen receptor alpha network—PGR—migraine	0.00171	0.0114	CbGpPWpGaD
Mesalazine—IKBKB—Estrogen signaling pathway—FOS—migraine	0.00169	0.0112	CbGpPWpGaD
Mesalazine—MPO—nervous system—migraine	0.00164	0.0185	CbGeAlD
Mesalazine—PTGS2—trigeminal ganglion—migraine	0.0016	0.0181	CbGeAlD
Mesalazine—Dopamine—SLC6A4—migraine	0.00158	0.27	CrCbGaD
Mesalazine—MPO—central nervous system—migraine	0.00158	0.0179	CbGeAlD
Mesalazine—PPARG—head—migraine	0.00154	0.0174	CbGeAlD
Mesalazine—ALOX5—brain—migraine	0.00148	0.0168	CbGeAlD
Mesalazine—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.00147	0.00982	CbGpPWpGaD
Mesalazine—PPARG—Nuclear Receptors—ESR1—migraine	0.00147	0.0098	CbGpPWpGaD
Mesalazine—CHUK—Osteopontin-mediated events—FOS—migraine	0.00147	0.00976	CbGpPWpGaD
Mesalazine—PPARG—nervous system—migraine	0.00146	0.0165	CbGeAlD
Mesalazine—MPO—Selenium Micronutrient Network—MTHFR—migraine	0.00145	0.00964	CbGpPWpGaD
Mesalazine—PPARG—central nervous system—migraine	0.0014	0.0158	CbGeAlD
Mesalazine—ALOX5—Selenium Micronutrient Network—MTHFR—migraine	0.00137	0.0091	CbGpPWpGaD
Mesalazine—MPO—brain—migraine	0.00125	0.0142	CbGeAlD
Mesalazine—MPO—IL23-mediated signaling events—TNF—migraine	0.00125	0.00831	CbGpPWpGaD
Mesalazine—CHUK—PDGF Pathway—FOS—migraine	0.00122	0.00812	CbGpPWpGaD
Mesalazine—PTGS1—cardiovascular system—migraine	0.00121	0.0137	CbGeAlD
Mesalazine—PPARG—Nuclear Receptor transcription pathway—ESR1—migraine	0.00116	0.00775	CbGpPWpGaD
Mesalazine—PTGS2—cardiovascular system—migraine	0.00116	0.0131	CbGeAlD
Mesalazine—IKBKB—GMCSF-mediated signaling events—FOS—migraine	0.00115	0.00768	CbGpPWpGaD
Mesalazine—CHUK—p75(NTR)-mediated signaling—BDNF—migraine	0.00114	0.00762	CbGpPWpGaD
Mesalazine—PPARG—brain—migraine	0.00111	0.0126	CbGeAlD
Mesalazine—PPARG—Transcription factor regulation in adipogenesis—TNF—migraine	0.0011	0.00736	CbGpPWpGaD
Mesalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—migraine	0.00107	0.00709	CbGpPWpGaD
Mesalazine—CHUK—Structural Pathway of Interleukin 1 (IL-1)—FOS—migraine	0.00105	0.007	CbGpPWpGaD
Mesalazine—IKBKB—p75(NTR)-mediated signaling—BDNF—migraine	0.00104	0.00691	CbGpPWpGaD
Mesalazine—CHUK—Canonical NF-kappaB pathway—TNF—migraine	0.001	0.00666	CbGpPWpGaD
Mesalazine—CHUK—EBV LMP1 signaling—TNF—migraine	0.001	0.00666	CbGpPWpGaD
Mesalazine—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—migraine	0.000966	0.00644	CbGpPWpGaD
Mesalazine—MPO—Vitamin B12 Metabolism—TNF—migraine	0.000965	0.00643	CbGpPWpGaD
Mesalazine—IKBKB—Structural Pathway of Interleukin 1 (IL-1)—FOS—migraine	0.000953	0.00635	CbGpPWpGaD
Mesalazine—CHUK—IL-4 Signaling Pathway—FOS—migraine	0.00094	0.00626	CbGpPWpGaD
Mesalazine—IKBKB—Type II diabetes mellitus—TNF—migraine	0.00094	0.00626	CbGpPWpGaD
Mesalazine—CHUK—RANKL/RANK Signaling Pathway—FOS—migraine	0.000927	0.00617	CbGpPWpGaD
Mesalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOS—migraine	0.000916	0.0061	CbGpPWpGaD
Mesalazine—CHUK—Validated nuclear estrogen receptor alpha network—ESR1—migraine	0.000911	0.00607	CbGpPWpGaD
Mesalazine—IKBKB—Canonical NF-kappaB pathway—TNF—migraine	0.000907	0.00604	CbGpPWpGaD
Mesalazine—IKBKB—EBV LMP1 signaling—TNF—migraine	0.000907	0.00604	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—SCN1A—migraine	0.00089	0.00593	CbGpPWpGaD
Mesalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—migraine	0.000874	0.00582	CbGpPWpGaD
Mesalazine—PTGS1—Overview of nanoparticle effects—TNF—migraine	0.00087	0.00579	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—PGR—migraine	0.000854	0.00569	CbGpPWpGaD
Mesalazine—CHUK—Fc-epsilon receptor I signaling in mast cells—FOS—migraine	0.000853	0.00568	CbGpPWpGaD
Mesalazine—IKBKB—IL-4 Signaling Pathway—FOS—migraine	0.000853	0.00568	CbGpPWpGaD
Mesalazine—IKBKB—RANKL/RANK Signaling Pathway—FOS—migraine	0.00084	0.0056	CbGpPWpGaD
Mesalazine—PTGS1—head—migraine	0.000821	0.00928	CbGeAlD
Mesalazine—CHUK—Leptin signaling pathway—ESR1—migraine	0.000802	0.00534	CbGpPWpGaD
Mesalazine—CHUK—BCR signaling pathway—FOS—migraine	0.000791	0.00527	CbGpPWpGaD
Mesalazine—MPO—Folate Metabolism—TNF—migraine	0.000785	0.00523	CbGpPWpGaD
Mesalazine—PTGS2—head—migraine	0.000785	0.00887	CbGeAlD
Mesalazine—PTGS1—nervous system—migraine	0.000778	0.0088	CbGeAlD
Mesalazine—IKBKB—Fc-epsilon receptor I signaling in mast cells—FOS—migraine	0.000774	0.00515	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—SCN2A—migraine	0.000757	0.00504	CbGpPWpGaD
Mesalazine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—migraine	0.00075	0.00499	CbGpPWpGaD
Mesalazine—PTGS1—central nervous system—migraine	0.000749	0.00847	CbGeAlD
Mesalazine—PTGS2—nervous system—migraine	0.000744	0.00841	CbGeAlD
Mesalazine—IKBKB—Leptin signaling pathway—ESR1—migraine	0.000728	0.00484	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—NPS—migraine	0.000727	0.00484	CbGpPWpGaD
Mesalazine—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—FOS—migraine	0.000723	0.00482	CbGpPWpGaD
Mesalazine—IKBKB—BCR signaling pathway—FOS—migraine	0.000718	0.00478	CbGpPWpGaD
Mesalazine—PTGS2—central nervous system—migraine	0.000716	0.0081	CbGeAlD
Mesalazine—PPARG—Circadian rythm related genes—SLC6A4—migraine	0.000713	0.00475	CbGpPWpGaD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000703	0.00468	CbGpPWpGaD
Mesalazine—PTGS2—cerebellum—migraine	0.0007	0.00791	CbGeAlD
Mesalazine—PPARG—Developmental Biology—MEF2D—migraine	0.000692	0.00461	CbGpPWpGaD
Mesalazine—PTGS2—Overview of nanoparticle effects—TNF—migraine	0.000691	0.0046	CbGpPWpGaD
Mesalazine—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—FOS—migraine	0.000656	0.00437	CbGpPWpGaD
Mesalazine—CHUK—MyD88 cascade initiated on plasma membrane—FOS—migraine	0.000654	0.00436	CbGpPWpGaD
Mesalazine—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—FOS—migraine	0.000648	0.00432	CbGpPWpGaD
Mesalazine—CHUK—MyD88 dependent cascade initiated on endosome—FOS—migraine	0.000636	0.00424	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000635	0.00423	CbGpPWpGaD
Mesalazine—CHUK—BDNF signaling pathway—BDNF—migraine	0.000635	0.00423	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—FOS—migraine	0.000625	0.00416	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—HTR7—migraine	0.000625	0.00416	CbGpPWpGaD
Mesalazine—MPO—Selenium Micronutrient Network—TNF—migraine	0.000624	0.00415	CbGpPWpGaD
Mesalazine—CHUK—TWEAK Signaling Pathway—TNF—migraine	0.000618	0.00412	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 9 (TLR9) Cascade—FOS—migraine	0.000614	0.00409	CbGpPWpGaD
Mesalazine—CHUK—MyD88:Mal cascade initiated on plasma membrane—FOS—migraine	0.000604	0.00402	CbGpPWpGaD
Mesalazine—PTGS1—brain—migraine	0.000595	0.00673	CbGeAlD
Mesalazine—IKBKB—MyD88 cascade initiated on plasma membrane—FOS—migraine	0.000593	0.00395	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—MTHFR—migraine	0.000593	0.00395	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—migraine	0.000592	0.00395	CbGpPWpGaD
Mesalazine—ALOX5—Selenium Micronutrient Network—TNF—migraine	0.000589	0.00392	CbGpPWpGaD
Mesalazine—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—FOS—migraine	0.000588	0.00391	CbGpPWpGaD
Mesalazine—CHUK—MyD88-independent cascade—FOS—migraine	0.000579	0.00386	CbGpPWpGaD
Mesalazine—IKBKB—MyD88 dependent cascade initiated on endosome—FOS—migraine	0.000577	0.00384	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—BDNF—migraine	0.000576	0.00383	CbGpPWpGaD
Mesalazine—CHUK—TNF receptor signaling pathway —TNF—migraine	0.000575	0.00383	CbGpPWpGaD
Mesalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—migraine	0.000573	0.00381	CbGpPWpGaD
Mesalazine—PTGS2—brain—migraine	0.000569	0.00643	CbGeAlD
Mesalazine—IKBKB—TCR Signaling Pathway—FOS—migraine	0.000567	0.00377	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—FOS—migraine	0.000565	0.00377	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—FOS—migraine	0.000562	0.00374	CbGpPWpGaD
Mesalazine—IKBKB—TWEAK Signaling Pathway—TNF—migraine	0.000561	0.00373	CbGpPWpGaD
Mesalazine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—FOS—migraine	0.000557	0.00371	CbGpPWpGaD
Mesalazine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—FOS—migraine	0.000547	0.00364	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TGFBR2—migraine	0.000529	0.00352	CbGpPWpGaD
Mesalazine—IKBKB—MyD88-independent cascade—FOS—migraine	0.000525	0.0035	CbGpPWpGaD
Mesalazine—IKBKB—TNF receptor signaling pathway —TNF—migraine	0.000521	0.00347	CbGpPWpGaD
Mesalazine—CHUK—Activated TLR4 signalling—FOS—migraine	0.000521	0.00347	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—FOS—migraine	0.000513	0.00341	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—BDNF—migraine	0.000509	0.00339	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000507	0.00337	CbGpPWpGaD
Mesalazine—CHUK—Cardiac Hypertrophic Response—TNF—migraine	0.000498	0.00332	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—FOS—migraine	0.00049	0.00326	CbGpPWpGaD
Mesalazine—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.000475	0.00316	CbGpPWpGaD
Mesalazine—IKBKB—Activated TLR4 signalling—FOS—migraine	0.000472	0.00315	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—MTHFR—migraine	0.000471	0.00313	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—ESR1—migraine	0.000458	0.00305	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—ESR1—migraine	0.000456	0.00304	CbGpPWpGaD
Mesalazine—IKBKB—Cardiac Hypertrophic Response—TNF—migraine	0.000452	0.00301	CbGpPWpGaD
Mesalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—FOS—migraine	0.000444	0.00296	CbGpPWpGaD
Mesalazine—Mental disorder—Gabapentin—migraine	0.000442	0.000599	CcSEcCtD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—FOS—migraine	0.000441	0.00294	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—BDNF—migraine	0.000441	0.00294	CbGpPWpGaD
Mesalazine—Agranulocytosis—Topiramate—migraine	0.000441	0.000598	CcSEcCtD
Mesalazine—Dry mouth—Valproic Acid—migraine	0.000441	0.000598	CcSEcCtD
Mesalazine—Erythema—Gabapentin—migraine	0.000439	0.000595	CcSEcCtD
Mesalazine—Dizziness—Propranolol—migraine	0.000438	0.000594	CcSEcCtD
Mesalazine—PPARG—Signaling events mediated by HDAC Class I—TNF—migraine	0.000438	0.00291	CbGpPWpGaD
Mesalazine—Asthenia—Verapamil—migraine	0.000437	0.000593	CcSEcCtD
Mesalazine—CHUK—Toll-Like Receptors Cascades—FOS—migraine	0.000436	0.00291	CbGpPWpGaD
Mesalazine—Confusional state—Valproic Acid—migraine	0.000436	0.000591	CcSEcCtD
Mesalazine—Flatulence—Gabapentin—migraine	0.000433	0.000587	CcSEcCtD
Mesalazine—Anaphylactic shock—Valproic Acid—migraine	0.000432	0.000586	CcSEcCtD
Mesalazine—Oedema—Valproic Acid—migraine	0.000432	0.000586	CcSEcCtD
Mesalazine—Pruritus—Verapamil—migraine	0.000431	0.000585	CcSEcCtD
Mesalazine—Tension—Gabapentin—migraine	0.000431	0.000584	CcSEcCtD
Mesalazine—Angioedema—Timolol—migraine	0.000431	0.000584	CcSEcCtD
Mesalazine—Dysgeusia—Gabapentin—migraine	0.00043	0.000583	CcSEcCtD
Mesalazine—Infection—Valproic Acid—migraine	0.000429	0.000582	CcSEcCtD
Mesalazine—CHUK—BDNF signaling pathway—FOS—migraine	0.000429	0.00286	CbGpPWpGaD
Mesalazine—Haemoglobin—Topiramate—migraine	0.000426	0.000578	CcSEcCtD
Mesalazine—Nervousness—Gabapentin—migraine	0.000426	0.000578	CcSEcCtD
Mesalazine—Rhinitis—Topiramate—migraine	0.000425	0.000577	CcSEcCtD
Mesalazine—Back pain—Gabapentin—migraine	0.000425	0.000576	CcSEcCtD
Mesalazine—Hepatitis—Topiramate—migraine	0.000424	0.000575	CcSEcCtD
Mesalazine—Haemorrhage—Topiramate—migraine	0.000424	0.000575	CcSEcCtD
Mesalazine—Nervous system disorder—Valproic Acid—migraine	0.000424	0.000575	CcSEcCtD
Mesalazine—Vertigo—Timolol—migraine	0.000423	0.000574	CcSEcCtD
Mesalazine—Thrombocytopenia—Valproic Acid—migraine	0.000423	0.000574	CcSEcCtD
Mesalazine—Syncope—Timolol—migraine	0.000423	0.000573	CcSEcCtD
Mesalazine—Muscle spasms—Gabapentin—migraine	0.000422	0.000572	CcSEcCtD
Mesalazine—Tachycardia—Valproic Acid—migraine	0.000422	0.000572	CcSEcCtD
Mesalazine—Vomiting—Propranolol—migraine	0.000421	0.000571	CcSEcCtD
Mesalazine—Pharyngitis—Topiramate—migraine	0.000421	0.000571	CcSEcCtD
Mesalazine—Skin disorder—Valproic Acid—migraine	0.00042	0.000569	CcSEcCtD
Mesalazine—Urinary tract disorder—Topiramate—migraine	0.000419	0.000568	CcSEcCtD
Mesalazine—Oedema peripheral—Topiramate—migraine	0.000418	0.000567	CcSEcCtD
Mesalazine—Hyperhidrosis—Valproic Acid—migraine	0.000418	0.000567	CcSEcCtD
Mesalazine—Rash—Propranolol—migraine	0.000418	0.000567	CcSEcCtD
Mesalazine—Dermatitis—Propranolol—migraine	0.000417	0.000566	CcSEcCtD
Mesalazine—Diarrhoea—Verapamil—migraine	0.000417	0.000566	CcSEcCtD
Mesalazine—Connective tissue disorder—Topiramate—migraine	0.000417	0.000565	CcSEcCtD
Mesalazine—Palpitations—Timolol—migraine	0.000417	0.000565	CcSEcCtD
Mesalazine—Urethral disorder—Topiramate—migraine	0.000416	0.000564	CcSEcCtD
Mesalazine—Loss of consciousness—Timolol—migraine	0.000414	0.000562	CcSEcCtD
Mesalazine—Vision blurred—Gabapentin—migraine	0.000414	0.000561	CcSEcCtD
Mesalazine—ALOX5—Metabolism—CACNA1A—migraine	0.000413	0.00275	CbGpPWpGaD
Mesalazine—Anorexia—Valproic Acid—migraine	0.000412	0.000559	CcSEcCtD
Mesalazine—PPARG—Generic Transcription Pathway—NOTCH4—migraine	0.000412	0.00274	CbGpPWpGaD
Mesalazine—Cough—Timolol—migraine	0.000411	0.000558	CcSEcCtD
Mesalazine—Tremor—Gabapentin—migraine	0.000411	0.000558	CcSEcCtD
Mesalazine—Ill-defined disorder—Gabapentin—migraine	0.000407	0.000552	CcSEcCtD
Mesalazine—Hypertension—Timolol—migraine	0.000407	0.000552	CcSEcCtD
Mesalazine—Anaemia—Gabapentin—migraine	0.000406	0.00055	CcSEcCtD
Mesalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—migraine	0.000405	0.0027	CbGpPWpGaD
Mesalazine—Hypotension—Valproic Acid—migraine	0.000404	0.000548	CcSEcCtD
Mesalazine—Dizziness—Verapamil—migraine	0.000403	0.000547	CcSEcCtD
Mesalazine—Arthralgia—Timolol—migraine	0.000401	0.000544	CcSEcCtD
Mesalazine—Myalgia—Timolol—migraine	0.000401	0.000544	CcSEcCtD
Mesalazine—Chest pain—Timolol—migraine	0.000401	0.000544	CcSEcCtD
Mesalazine—Erythema multiforme—Topiramate—migraine	0.000401	0.000544	CcSEcCtD
Mesalazine—Angioedema—Gabapentin—migraine	0.000401	0.000544	CcSEcCtD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—FOS—migraine	0.0004	0.00267	CbGpPWpGaD
Mesalazine—Anxiety—Timolol—migraine	0.0004	0.000542	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000399	0.00054	CcSEcCtD
Mesalazine—Discomfort—Timolol—migraine	0.000396	0.000538	CcSEcCtD
Mesalazine—Eye disorder—Topiramate—migraine	0.000396	0.000538	CcSEcCtD
Mesalazine—Malaise—Gabapentin—migraine	0.000396	0.000537	CcSEcCtD
Mesalazine—IKBKB—Toll-Like Receptors Cascades—FOS—migraine	0.000396	0.00263	CbGpPWpGaD
Mesalazine—Tinnitus—Topiramate—migraine	0.000396	0.000536	CcSEcCtD
Mesalazine—Vertigo—Gabapentin—migraine	0.000394	0.000535	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Valproic Acid—migraine	0.000394	0.000534	CcSEcCtD
Mesalazine—Cardiac disorder—Topiramate—migraine	0.000394	0.000534	CcSEcCtD
Mesalazine—Syncope—Gabapentin—migraine	0.000394	0.000534	CcSEcCtD
Mesalazine—Nausea—Propranolol—migraine	0.000394	0.000534	CcSEcCtD
Mesalazine—Leukopenia—Gabapentin—migraine	0.000393	0.000533	CcSEcCtD
Mesalazine—Dry mouth—Timolol—migraine	0.000392	0.000532	CcSEcCtD
Mesalazine—Insomnia—Valproic Acid—migraine	0.000391	0.00053	CcSEcCtD
Mesalazine—IKBKB—BDNF signaling pathway—FOS—migraine	0.000389	0.00259	CbGpPWpGaD
Mesalazine—Paraesthesia—Valproic Acid—migraine	0.000388	0.000526	CcSEcCtD
Mesalazine—Palpitations—Gabapentin—migraine	0.000388	0.000526	CcSEcCtD
Mesalazine—Confusional state—Timolol—migraine	0.000388	0.000526	CcSEcCtD
Mesalazine—Vomiting—Verapamil—migraine	0.000388	0.000526	CcSEcCtD
Mesalazine—Loss of consciousness—Gabapentin—migraine	0.000386	0.000523	CcSEcCtD
Mesalazine—Dyspnoea—Valproic Acid—migraine	0.000385	0.000522	CcSEcCtD
Mesalazine—Angiopathy—Topiramate—migraine	0.000385	0.000522	CcSEcCtD
Mesalazine—Oedema—Timolol—migraine	0.000385	0.000522	CcSEcCtD
Mesalazine—Anaphylactic shock—Timolol—migraine	0.000385	0.000522	CcSEcCtD
Mesalazine—Rash—Verapamil—migraine	0.000384	0.000521	CcSEcCtD
Mesalazine—Somnolence—Valproic Acid—migraine	0.000384	0.000521	CcSEcCtD
Mesalazine—Dermatitis—Verapamil—migraine	0.000384	0.000521	CcSEcCtD
Mesalazine—Immune system disorder—Topiramate—migraine	0.000383	0.00052	CcSEcCtD
Mesalazine—Cough—Gabapentin—migraine	0.000383	0.000519	CcSEcCtD
Mesalazine—Mediastinal disorder—Topiramate—migraine	0.000382	0.000519	CcSEcCtD
Mesalazine—Infection—Timolol—migraine	0.000382	0.000518	CcSEcCtD
Mesalazine—Headache—Verapamil—migraine	0.000382	0.000518	CcSEcCtD
Mesalazine—Chills—Topiramate—migraine	0.000381	0.000516	CcSEcCtD
Mesalazine—Dyspepsia—Valproic Acid—migraine	0.00038	0.000516	CcSEcCtD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.00038	0.00253	CbGpPWpGaD
Mesalazine—Hypertension—Gabapentin—migraine	0.000379	0.000514	CcSEcCtD
Mesalazine—Shock—Timolol—migraine	0.000378	0.000513	CcSEcCtD
Mesalazine—Nervous system disorder—Timolol—migraine	0.000377	0.000512	CcSEcCtD
Mesalazine—PPARG—Generic Transcription Pathway—PGR—migraine	0.000376	0.00251	CbGpPWpGaD
Mesalazine—Decreased appetite—Valproic Acid—migraine	0.000376	0.000509	CcSEcCtD
Mesalazine—Alopecia—Topiramate—migraine	0.000375	0.000508	CcSEcCtD
Mesalazine—Arthralgia—Gabapentin—migraine	0.000374	0.000507	CcSEcCtD
Mesalazine—Chest pain—Gabapentin—migraine	0.000374	0.000507	CcSEcCtD
Mesalazine—Myalgia—Gabapentin—migraine	0.000374	0.000507	CcSEcCtD
Mesalazine—Skin disorder—Timolol—migraine	0.000374	0.000507	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Valproic Acid—migraine	0.000373	0.000506	CcSEcCtD
Mesalazine—Fatigue—Valproic Acid—migraine	0.000373	0.000505	CcSEcCtD
Mesalazine—Anxiety—Gabapentin—migraine	0.000372	0.000505	CcSEcCtD
Mesalazine—Hyperhidrosis—Timolol—migraine	0.000372	0.000504	CcSEcCtD
Mesalazine—Mental disorder—Topiramate—migraine	0.000372	0.000504	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000371	0.000503	CcSEcCtD
Mesalazine—Constipation—Valproic Acid—migraine	0.00037	0.000501	CcSEcCtD
Mesalazine—Pain—Valproic Acid—migraine	0.00037	0.000501	CcSEcCtD
Mesalazine—Erythema—Topiramate—migraine	0.000369	0.000501	CcSEcCtD
Mesalazine—Discomfort—Gabapentin—migraine	0.000369	0.000501	CcSEcCtD
Mesalazine—Anorexia—Timolol—migraine	0.000367	0.000497	CcSEcCtD
Mesalazine—Dry mouth—Gabapentin—migraine	0.000365	0.000496	CcSEcCtD
Mesalazine—Flatulence—Topiramate—migraine	0.000364	0.000494	CcSEcCtD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000364	0.00242	CbGpPWpGaD
Mesalazine—Tension—Topiramate—migraine	0.000362	0.000491	CcSEcCtD
Mesalazine—Nausea—Verapamil—migraine	0.000362	0.000491	CcSEcCtD
Mesalazine—Dysgeusia—Topiramate—migraine	0.000362	0.00049	CcSEcCtD
Mesalazine—Confusional state—Gabapentin—migraine	0.000361	0.00049	CcSEcCtD
Mesalazine—Hypotension—Timolol—migraine	0.000359	0.000488	CcSEcCtD
Mesalazine—Nervousness—Topiramate—migraine	0.000359	0.000486	CcSEcCtD
Mesalazine—Oedema—Gabapentin—migraine	0.000358	0.000486	CcSEcCtD
Mesalazine—Anaphylactic shock—Gabapentin—migraine	0.000358	0.000486	CcSEcCtD
Mesalazine—IKBKB—Insulin Signaling—FOS—migraine	0.000358	0.00238	CbGpPWpGaD
Mesalazine—Back pain—Topiramate—migraine	0.000357	0.000484	CcSEcCtD
Mesalazine—Feeling abnormal—Valproic Acid—migraine	0.000356	0.000483	CcSEcCtD
Mesalazine—Infection—Gabapentin—migraine	0.000356	0.000483	CcSEcCtD
Mesalazine—CHUK—Apoptosis—TNF—migraine	0.000355	0.00236	CbGpPWpGaD
Mesalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	0.000355	0.00236	CbGpPWpGaD
Mesalazine—Muscle spasms—Topiramate—migraine	0.000355	0.000482	CcSEcCtD
Mesalazine—Gastrointestinal pain—Valproic Acid—migraine	0.000353	0.000479	CcSEcCtD
Mesalazine—Shock—Gabapentin—migraine	0.000352	0.000478	CcSEcCtD
Mesalazine—Nervous system disorder—Gabapentin—migraine	0.000351	0.000476	CcSEcCtD
Mesalazine—Thrombocytopenia—Gabapentin—migraine	0.000351	0.000476	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Timolol—migraine	0.00035	0.000475	CcSEcCtD
Mesalazine—PPARG—Generic Transcription Pathway—NOTCH3—migraine	0.00035	0.00233	CbGpPWpGaD
Mesalazine—Tachycardia—Gabapentin—migraine	0.00035	0.000474	CcSEcCtD
Mesalazine—Vision blurred—Topiramate—migraine	0.000348	0.000472	CcSEcCtD
Mesalazine—Skin disorder—Gabapentin—migraine	0.000348	0.000472	CcSEcCtD
Mesalazine—Insomnia—Timolol—migraine	0.000348	0.000472	CcSEcCtD
Mesalazine—Hyperhidrosis—Gabapentin—migraine	0.000346	0.00047	CcSEcCtD
Mesalazine—Tremor—Topiramate—migraine	0.000346	0.000469	CcSEcCtD
Mesalazine—Paraesthesia—Timolol—migraine	0.000345	0.000468	CcSEcCtD
Mesalazine—IKBKB—MAPK Signaling Pathway—FOS—migraine	0.000344	0.00229	CbGpPWpGaD
Mesalazine—Urticaria—Valproic Acid—migraine	0.000343	0.000466	CcSEcCtD
Mesalazine—Dyspnoea—Timolol—migraine	0.000343	0.000465	CcSEcCtD
Mesalazine—Ill-defined disorder—Topiramate—migraine	0.000343	0.000465	CcSEcCtD
Mesalazine—Somnolence—Timolol—migraine	0.000342	0.000464	CcSEcCtD
Mesalazine—Abdominal pain—Valproic Acid—migraine	0.000342	0.000463	CcSEcCtD
Mesalazine—Body temperature increased—Valproic Acid—migraine	0.000342	0.000463	CcSEcCtD
Mesalazine—Anorexia—Gabapentin—migraine	0.000341	0.000463	CcSEcCtD
Mesalazine—Anaemia—Topiramate—migraine	0.000341	0.000463	CcSEcCtD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—TNF—migraine	0.00034	0.00227	CbGpPWpGaD
Mesalazine—Dyspepsia—Timolol—migraine	0.000339	0.000459	CcSEcCtD
Mesalazine—Hypotension—Gabapentin—migraine	0.000335	0.000454	CcSEcCtD
Mesalazine—Decreased appetite—Timolol—migraine	0.000334	0.000454	CcSEcCtD
Mesalazine—Malaise—Topiramate—migraine	0.000333	0.000452	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Timolol—migraine	0.000332	0.00045	CcSEcCtD
Mesalazine—Vertigo—Topiramate—migraine	0.000332	0.00045	CcSEcCtD
Mesalazine—Fatigue—Timolol—migraine	0.000332	0.00045	CcSEcCtD
Mesalazine—Syncope—Topiramate—migraine	0.000331	0.000449	CcSEcCtD
Mesalazine—Leukopenia—Topiramate—migraine	0.000331	0.000448	CcSEcCtD
Mesalazine—CHUK—TNF alpha Signaling Pathway—TNF—migraine	0.00033	0.0022	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.00033	0.0022	CbGpPWpGaD
Mesalazine—Pain—Timolol—migraine	0.000329	0.000446	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Gabapentin—migraine	0.000326	0.000443	CcSEcCtD
Mesalazine—Palpitations—Topiramate—migraine	0.000326	0.000443	CcSEcCtD
Mesalazine—Loss of consciousness—Topiramate—migraine	0.000325	0.00044	CcSEcCtD
Mesalazine—Insomnia—Gabapentin—migraine	0.000324	0.000439	CcSEcCtD
Mesalazine—Cough—Topiramate—migraine	0.000322	0.000437	CcSEcCtD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	0.000322	0.00214	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—TNF—migraine	0.000322	0.00214	CbGpPWpGaD
Mesalazine—Paraesthesia—Gabapentin—migraine	0.000322	0.000436	CcSEcCtD
Mesalazine—Dyspnoea—Gabapentin—migraine	0.000319	0.000433	CcSEcCtD
Mesalazine—Hypertension—Topiramate—migraine	0.000319	0.000432	CcSEcCtD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—migraine	0.000319	0.00212	CbGpPWpGaD
Mesalazine—Somnolence—Gabapentin—migraine	0.000318	0.000432	CcSEcCtD
Mesalazine—Hypersensitivity—Valproic Acid—migraine	0.000318	0.000432	CcSEcCtD
Mesalazine—Feeling abnormal—Timolol—migraine	0.000317	0.00043	CcSEcCtD
Mesalazine—Dyspepsia—Gabapentin—migraine	0.000315	0.000428	CcSEcCtD
Mesalazine—Gastrointestinal pain—Timolol—migraine	0.000315	0.000427	CcSEcCtD
Mesalazine—Arthralgia—Topiramate—migraine	0.000314	0.000426	CcSEcCtD
Mesalazine—Chest pain—Topiramate—migraine	0.000314	0.000426	CcSEcCtD
Mesalazine—Myalgia—Topiramate—migraine	0.000314	0.000426	CcSEcCtD
Mesalazine—Anxiety—Topiramate—migraine	0.000313	0.000425	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000312	0.000423	CcSEcCtD
Mesalazine—Decreased appetite—Gabapentin—migraine	0.000311	0.000422	CcSEcCtD
Mesalazine—Discomfort—Topiramate—migraine	0.000311	0.000421	CcSEcCtD
Mesalazine—Asthenia—Valproic Acid—migraine	0.00031	0.00042	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Gabapentin—migraine	0.000309	0.000419	CcSEcCtD
Mesalazine—Fatigue—Gabapentin—migraine	0.000309	0.000419	CcSEcCtD
Mesalazine—Dry mouth—Topiramate—migraine	0.000307	0.000417	CcSEcCtD
Mesalazine—Pain—Gabapentin—migraine	0.000306	0.000415	CcSEcCtD
Mesalazine—Constipation—Gabapentin—migraine	0.000306	0.000415	CcSEcCtD
Mesalazine—Pruritus—Valproic Acid—migraine	0.000306	0.000415	CcSEcCtD
Mesalazine—Urticaria—Timolol—migraine	0.000306	0.000414	CcSEcCtD
Mesalazine—Abdominal pain—Timolol—migraine	0.000304	0.000412	CcSEcCtD
Mesalazine—Body temperature increased—Timolol—migraine	0.000304	0.000412	CcSEcCtD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—TNF—migraine	0.000304	0.00202	CbGpPWpGaD
Mesalazine—Confusional state—Topiramate—migraine	0.000304	0.000412	CcSEcCtD
Mesalazine—Oedema—Topiramate—migraine	0.000301	0.000409	CcSEcCtD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.0003	0.002	CbGpPWpGaD
Mesalazine—Infection—Topiramate—migraine	0.000299	0.000406	CcSEcCtD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—TNF—migraine	0.000299	0.00199	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—FOS—migraine	0.000298	0.00198	CbGpPWpGaD
Mesalazine—Shock—Topiramate—migraine	0.000297	0.000402	CcSEcCtD
Mesalazine—Diarrhoea—Valproic Acid—migraine	0.000296	0.000401	CcSEcCtD
Mesalazine—Nervous system disorder—Topiramate—migraine	0.000296	0.000401	CcSEcCtD
Mesalazine—Feeling abnormal—Gabapentin—migraine	0.000295	0.0004	CcSEcCtD
Mesalazine—Thrombocytopenia—Topiramate—migraine	0.000295	0.0004	CcSEcCtD
Mesalazine—Tachycardia—Topiramate—migraine	0.000294	0.000399	CcSEcCtD
Mesalazine—Gastrointestinal pain—Gabapentin—migraine	0.000293	0.000397	CcSEcCtD
Mesalazine—Skin disorder—Topiramate—migraine	0.000293	0.000397	CcSEcCtD
Mesalazine—Hyperhidrosis—Topiramate—migraine	0.000291	0.000395	CcSEcCtD
Mesalazine—Anorexia—Topiramate—migraine	0.000287	0.00039	CcSEcCtD
Mesalazine—Dizziness—Valproic Acid—migraine	0.000286	0.000388	CcSEcCtD
Mesalazine—Urticaria—Gabapentin—migraine	0.000285	0.000386	CcSEcCtD
Mesalazine—Hypersensitivity—Timolol—migraine	0.000283	0.000384	CcSEcCtD
Mesalazine—Abdominal pain—Gabapentin—migraine	0.000283	0.000384	CcSEcCtD
Mesalazine—Body temperature increased—Gabapentin—migraine	0.000283	0.000384	CcSEcCtD
Mesalazine—Hypotension—Topiramate—migraine	0.000282	0.000382	CcSEcCtD
Mesalazine—Asthenia—Timolol—migraine	0.000276	0.000374	CcSEcCtD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—migraine	0.000276	0.00184	CbGpPWpGaD
Mesalazine—Vomiting—Valproic Acid—migraine	0.000275	0.000373	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Topiramate—migraine	0.000275	0.000372	CcSEcCtD
Mesalazine—Insomnia—Topiramate—migraine	0.000273	0.00037	CcSEcCtD
Mesalazine—Rash—Valproic Acid—migraine	0.000272	0.00037	CcSEcCtD
Mesalazine—Dermatitis—Valproic Acid—migraine	0.000272	0.000369	CcSEcCtD
Mesalazine—Pruritus—Timolol—migraine	0.000272	0.000369	CcSEcCtD
Mesalazine—Headache—Valproic Acid—migraine	0.000271	0.000367	CcSEcCtD
Mesalazine—Paraesthesia—Topiramate—migraine	0.000271	0.000367	CcSEcCtD
Mesalazine—Dyspnoea—Topiramate—migraine	0.000269	0.000364	CcSEcCtD
Mesalazine—Somnolence—Topiramate—migraine	0.000268	0.000363	CcSEcCtD
Mesalazine—PPARG—Adipogenesis—TNF—migraine	0.000267	0.00178	CbGpPWpGaD
Mesalazine—Dyspepsia—Topiramate—migraine	0.000265	0.00036	CcSEcCtD
Mesalazine—CHUK—Signaling Pathways—RAMP1—migraine	0.000265	0.00177	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CALCRL—migraine	0.000265	0.00177	CbGpPWpGaD
Mesalazine—Hypersensitivity—Gabapentin—migraine	0.000264	0.000358	CcSEcCtD
Mesalazine—Diarrhoea—Timolol—migraine	0.000263	0.000357	CcSEcCtD
Mesalazine—Decreased appetite—Topiramate—migraine	0.000262	0.000355	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Topiramate—migraine	0.00026	0.000353	CcSEcCtD
Mesalazine—Fatigue—Topiramate—migraine	0.00026	0.000352	CcSEcCtD
Mesalazine—Constipation—Topiramate—migraine	0.000258	0.00035	CcSEcCtD
Mesalazine—Pain—Topiramate—migraine	0.000258	0.00035	CcSEcCtD
Mesalazine—Asthenia—Gabapentin—migraine	0.000257	0.000349	CcSEcCtD
Mesalazine—Nausea—Valproic Acid—migraine	0.000257	0.000348	CcSEcCtD
Mesalazine—PPARG—Metabolism—CACNA1A—migraine	0.000256	0.0017	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—TNF—migraine	0.000255	0.0017	CbGpPWpGaD
Mesalazine—Dizziness—Timolol—migraine	0.000254	0.000345	CcSEcCtD
Mesalazine—Pruritus—Gabapentin—migraine	0.000253	0.000344	CcSEcCtD
Mesalazine—Feeling abnormal—Topiramate—migraine	0.000248	0.000337	CcSEcCtD
Mesalazine—Gastrointestinal pain—Topiramate—migraine	0.000246	0.000334	CcSEcCtD
Mesalazine—Diarrhoea—Gabapentin—migraine	0.000245	0.000332	CcSEcCtD
Mesalazine—Vomiting—Timolol—migraine	0.000245	0.000332	CcSEcCtD
Mesalazine—Rash—Timolol—migraine	0.000243	0.000329	CcSEcCtD
Mesalazine—Dermatitis—Timolol—migraine	0.000242	0.000329	CcSEcCtD
Mesalazine—Headache—Timolol—migraine	0.000241	0.000327	CcSEcCtD
Mesalazine—IKBKB—Signaling Pathways—RAMP1—migraine	0.00024	0.0016	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CALCRL—migraine	0.00024	0.0016	CbGpPWpGaD
Mesalazine—Urticaria—Topiramate—migraine	0.000239	0.000325	CcSEcCtD
Mesalazine—Abdominal pain—Topiramate—migraine	0.000238	0.000323	CcSEcCtD
Mesalazine—Body temperature increased—Topiramate—migraine	0.000238	0.000323	CcSEcCtD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—migraine	0.000237	0.00158	CbGpPWpGaD
Mesalazine—Dizziness—Gabapentin—migraine	0.000237	0.000321	CcSEcCtD
Mesalazine—Nausea—Timolol—migraine	0.000229	0.00031	CcSEcCtD
Mesalazine—Vomiting—Gabapentin—migraine	0.000228	0.000309	CcSEcCtD
Mesalazine—Rash—Gabapentin—migraine	0.000226	0.000306	CcSEcCtD
Mesalazine—Dermatitis—Gabapentin—migraine	0.000226	0.000306	CcSEcCtD
Mesalazine—CHUK—Disease—LRP1—migraine	0.000225	0.0015	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000225	0.0015	CbGpPWpGaD
Mesalazine—Headache—Gabapentin—migraine	0.000224	0.000304	CcSEcCtD
Mesalazine—Hypersensitivity—Topiramate—migraine	0.000222	0.000301	CcSEcCtD
Mesalazine—Asthenia—Topiramate—migraine	0.000216	0.000293	CcSEcCtD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—migraine	0.000215	0.00143	CbGpPWpGaD
Mesalazine—Pruritus—Topiramate—migraine	0.000213	0.000289	CcSEcCtD
Mesalazine—Nausea—Gabapentin—migraine	0.000213	0.000289	CcSEcCtD
Mesalazine—Diarrhoea—Topiramate—migraine	0.000206	0.00028	CcSEcCtD
Mesalazine—PTGS2—Selenium Micronutrient Network—TNF—migraine	0.000203	0.00135	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—ESR1—migraine	0.000201	0.00134	CbGpPWpGaD
Mesalazine—Dizziness—Topiramate—migraine	0.000199	0.00027	CcSEcCtD
Mesalazine—PPARG—Gene Expression—NOTCH4—migraine	0.000198	0.00132	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR1D—migraine	0.000193	0.00128	CbGpPWpGaD
Mesalazine—Vomiting—Topiramate—migraine	0.000192	0.00026	CcSEcCtD
Mesalazine—Rash—Topiramate—migraine	0.00019	0.000258	CcSEcCtD
Mesalazine—Dermatitis—Topiramate—migraine	0.00019	0.000257	CcSEcCtD
Mesalazine—Headache—Topiramate—migraine	0.000189	0.000256	CcSEcCtD
Mesalazine—IKBKB—MAPK Signaling Pathway—TNF—migraine	0.000185	0.00123	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.000184	0.00123	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—PGR—migraine	0.000181	0.00121	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CACNA1A—migraine	0.000179	0.00119	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR2B—migraine	0.000179	0.00119	CbGpPWpGaD
Mesalazine—Nausea—Topiramate—migraine	0.000179	0.000243	CcSEcCtD
Mesalazine—IKBKB—Signaling Pathways—HTR1D—migraine	0.000175	0.00116	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—NOTCH3—migraine	0.000168	0.00112	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR2B—migraine	0.000162	0.00108	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—migraine	0.00016	0.00107	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LRP1—migraine	0.000158	0.00105	CbGpPWpGaD
Mesalazine—CHUK—Disease—CALCA—migraine	0.000145	0.000966	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LRP1—migraine	0.000143	0.000952	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CACNA1A—migraine	0.000142	0.000948	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—FOS—migraine	0.000141	0.000941	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—MTHFR—migraine	0.000137	0.000911	CbGpPWpGaD
Mesalazine—PTGS2—Disease—LRP1—migraine	0.000133	0.000888	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—FOS—migraine	0.000128	0.000854	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOTCH4—migraine	0.000121	0.000805	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFBR2—migraine	0.000117	0.000778	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR1B—migraine	0.000117	0.000777	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR1A—migraine	0.000112	0.000748	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PGR—migraine	0.000111	0.000737	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TAC1—migraine	0.000111	0.000737	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NPS—migraine	0.000111	0.000737	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOTCH4—migraine	0.00011	0.00073	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.000109	0.000726	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR2C—migraine	0.000108	0.000722	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR1B—migraine	0.000106	0.000705	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EDNRA—migraine	0.000106	0.000703	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOTCH3—migraine	0.000103	0.000685	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR1A—migraine	0.000102	0.000678	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CALCA—migraine	0.000102	0.000676	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PGR—migraine	0.0001	0.000668	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NPS—migraine	0.0001	0.000668	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TAC1—migraine	0.0001	0.000668	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR2C—migraine	9.84e-05	0.000655	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—ESR1—migraine	9.68e-05	0.000644	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EDNRA—migraine	9.57e-05	0.000637	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR7—migraine	9.5e-05	0.000633	CbGpPWpGaD
Mesalazine—CHUK—Disease—MTHFR—migraine	9.49e-05	0.000632	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOTCH3—migraine	9.33e-05	0.000621	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CALCA—migraine	9.21e-05	0.000613	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—migraine	9.17e-05	0.00061	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR7—migraine	8.62e-05	0.000574	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CALCA—migraine	8.59e-05	0.000572	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—MTHFR—migraine	8.47e-05	0.000564	CbGpPWpGaD
Mesalazine—CHUK—Immune System—FOS—migraine	8.23e-05	0.000548	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFBR2—migraine	8.18e-05	0.000545	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—FOS—migraine	7.47e-05	0.000497	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFBR2—migraine	7.42e-05	0.000494	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFBR2—migraine	6.92e-05	0.000461	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR2A—migraine	6.65e-05	0.000443	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR2A—migraine	6.03e-05	0.000402	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—MTHFR—migraine	5.93e-05	0.000395	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ESR1—migraine	5.91e-05	0.000393	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MTHFR—migraine	5.62e-05	0.000374	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ESR1—migraine	5.36e-05	0.000357	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MTHFR—migraine	4.71e-05	0.000313	CbGpPWpGaD
